Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in Chinese patients with hypokalemic periodic paralysis

American Journal of the Medical Sciences

Volumn 329, Issue 2, 2005, Pages 66-70

  Lin, Shih Hua ^a   Hsu, Yaw Don ^b   Cheng, Nai Lin ^a   Kao, Ming Ching ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Calcium channel; Familial; Hyperthyroidism; Hypokalemia; Paralysis; Sporadic

Indexed keywords

CALCIUM CHANNEL; DIHYDROPYRIDINE; POTASSIUM ION;

ADULT; ARTICLE; CACNA1S GENE; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; PEDIGREE; POLYMERASE CHAIN REACTION;

EID: 13844275563     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200502000-00003     Document Type: Article

References (34)

1. Stedwell RE, Allen KM, Binder LS. Hypokalemic paralyses: a review of the etiologies, pathophysiology, presentation and therapy. Am J Emerg Med 1992;10:143-6.
2. Lin SH, Lin YF, Halperin ML. Hypokalemia and paralysis. QJM 2001;94:133-9.
3. Ober KP. Thyrotoxic periodic paralysis in the United States: report of 7 cases and review of the literature. Medicine 1992;71:109-20.
4. Lapie P, Lory P, Fontaine B. Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel. Neuromuscul Disord 1997;7:234-40.
5. Ko GTC, Chow CC, Yeung VTF, et al. Thyrotoxic periodic paralysis in a Chinese population. QJM 1996;89:463-8.
6. Chen KW, Hung TP, Lin TY. Periodic paralysis in Taiwan: clinical study of 28 cases. Arch Neurol 1965;12:165-71.
7. Fontaine B, Vale-Santos J, Jurkat-Rott K, et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families. Nat Genet 1994;6:267-72.
8. Ptacek LJ, Tawil R, Griggs RC, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994;77:863-8.
9. 2+ channel (CAVNL1A3) to chromosome 1q31-q32. Genomics 1993;15:107-12.
10. Catterall WA. Structure and function of voltage-gated ion channels. Trends Neurosci 1993;16:500-6.
11. Tanabe T, Takeshima H, Mikami A, et al. Primary structure of the receptor for calcium channel blockers from skeketal muscle. Nature 1987;328:318-28.
12. Jurkat-Rott K, Lehmann-Horn F, Elbaz A, et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 1994;3:1415-9.
13. Elbaz A, Vale-Santos J, Jurkat-Rott K, et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet 1995;56:374-80.
14. Sillen A, Sorensen T, Kantola I, et al. Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families. Am J Med Genet 1997;69:102-6.
15. Fouad G, Dalakas M, Servidei S, et al. Genotype-phenotype correlations of DHP receptor α1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord 1997;7:33-8.
16. Dias da Silva MR, Cerutti JM, Tengan CH, et al. Mutations linked to familial hypokalemic periodic paralysis in the calcium channel alpha subunit gene (Cav1.1) are not associated with thyrotoxic hypokalemic periodic paralysis. Clin Endocrinol 2002;56:367-75.
17. Kung AW, Lau KS, Fong GC, et al. Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab 2004;89:1340-5.
18. Phakdeekitcharoen B, Ruangraksa C, Radinahamed P. Hypokalaemia and paralysis in the Thai population. Nephrol Dial Transplant 2004;19:2013-8.
19. John SW, Weitzner G, Rozen R, et al. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res 1991;19:408.
20. Grosson CL, Esteban J, McKenna-Yasek D, et al. Hypokalemic periodic paralysis mutations: confirmation of mutation and analysis of founder effect. Neuromuscul Disord 1996;6:27-31.
21. Kleopa KA, Barch RL. Genetic disorders of neuromuscular ion channels. Muscle Nerve 2002;26:299-325.
22. Plassart E, Elbaz A, Santos JV, et al. Genetic heterogeneity in hypokalemic periodic paralysis (hypoPP). Hum Genet 1994;94:551-6.
23. Bulman DE, Scoggan KA, van Oene MD, et al. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 1999;10:1932-6.
24. Jurkat-Rott K, Mitrovic N, Hang C, et al. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci USA 2000;97:9549-54.
25. Davies NP, Eunson LH, Samuel M, et al. Sodium channel gene mutations in hypokalemic periodic paralysis: an uncommon cause in the UK. Neurology 2001;9:1323-5.
26. Sternberg D, Maisonobe T, Jurkat-Rott K, et al. Hypokalemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 2001;124:1091-9.
27. Abbott GW, Butler MH, Bendahhou S, et al. MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. Cell 2001;104:217-31.
28. Scheinman SJ, Guay-Woodford LM, Thakker RV, et al. Genetic disorders of renal electrolyte transport. N Engl J Med 1999;340:1177-87.
29. Kim SH, Kim UK, Chae JJ, et al. Identification of mutations including de novo mutations in Korean patients with hypokalemic periodic paralysis. Nephrol Dial Transplant 2001;16:939-44.
30. Lin SH, Lin YF. Propranolol rapidly terminates the hypokalemia, hypophosphatemia and paralysis in thyrotoxic periodic paralysis. Am J Kidney Dis 2001;37:620-3.
31. Manoukain MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med 1999;159:601-6.
32. Gallagher EJ. Is thyrotoxic periodic paralysis a channelopathy? J Emerg Med 1999;17:123-7.
33. Ng WY, Lui KF, Thai AC, et al. Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis. Thyroid 2004;14:187-90.
34. Tang NL, Chow CC, Ko GT, et al. No mutation in the KCNE3 potassium channel gene in Chinese thyrotoxic hypokalaemic periodic paralysis patients. Clin Endocrinol 2004;61:109-12.